Showing results (261-270 of 602) with videos related to

Sort By:
Pageof 61
British Journal of Haematology|December 5, 2009
Impact of dexamethasone responsiveness on long term outcome in patients with newly diagnosed multiple myelomaShirshendu Sinha, S Vincent Rajkumar, Martha Q Lacy, et al.
British Journal of Haematology|October 4, 2005
Concomitant neutrophil JAK2 mutation screening and PRV-1 expression analysis in myeloproliferative disorders and secondary polycythaemiaAyalew Tefferi, Shireen Sirhan, Terra L Lasho, et al.
Elife|January 31, 2023
T-REX17 is a transiently expressed non-coding RNA essential for human endoderm formationAlexandro Landshammer, Adriano Bolondi, Helene Kretzmer, et al.
Experimental Hematology|December 18, 2021
Transcriptional differences between JAK2-V617F and wild-type bone marrow cells in patients with myeloproliferative neoplasmsDebra Van Egeren, Baransel Kamaz, Shichen Liu, et al.
Future Oncology (London, England)|December 19, 2025
Real-world cardiac events and outcomes in cBTKi-treated chronic lymphocytic leukemia patientsDavid Dingli, Enrico De Nigris, Siyang Leng, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 11, 2015
Trends and outcomes in allogeneic hematopoietic stem cell transplant for multiple myeloma at Mayo ClinicMuhammad A Mir, Prashant Kapoor, Shaji Kumar, et al.
British Journal of Haematology|July 21, 2005
Der(6)t(1;6)(q21-23;p21.3): a specific cytogenetic abnormality in myelofibrosis with myeloid metaplasiaDavid Dingli, Francis H Grand, Victor Mahaffey, et al.
Bone Marrow Transplantation|October 6, 2022
Impact of the time interval between end of induction and autologous hematopoietic transplantation in newly diagnosed patients with multiple myelomaCharalampos Charalampous, Utkarsh Goel, Morie Gertz, et al.
Annals of Hematology|November 17, 2024
Health-related quality of life and symptom-specific functional impairment among patients treated with parenterally administered complement inhibitors for paroxysmal nocturnal hemoglobinuriaDavid Dingli, Avery A Rizio, Lynne Broderick, et al.
Neuro-Oncology|November 19, 2022
Phase I study of a novel glioblastoma radiation therapy schedule exploiting cell-state plasticityJamie A Dean, Shyam K Tanguturi, Daniel Cagney, et al.
Pageof 61